Compare AbCellera Biologics Inc (ABCL) vs GXO Logistics Inc (GXO) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbCellera Biologics Inc vs GXO Logistics Inc — how do they compare? AbCellera Biologics Inc trades at $7.17 (market cap $2.35B), while GXO Logistics Inc trades at $49.01 (market cap $5.89B). The key difference: GXO Logistics Inc is far larger — about 2.5× AbCellera Biologics Inc's market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, GXO Logistics Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | GXO | |
|---|---|---|
Market Cap | $2.35B | $5.89B |
Sector | Health | Industrials |
52-Week High | $8.12 | $65.59 |
52-Week Low | $2.78 | $45.52 |
Enterprise Value | $1.99B | $11.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbCellera Biologics (ABCL) trades at $7.69, down 5.18% today, with a bullish technical signal from moving averages but overbought RSI readings. The company reported a net loss of -$146.41M in 2025, with negative margins, though revenue grew to $75.13M. Recent news highlights a major collaboration with Jazz Pharmaceuticals worth up to $876M, potentially boosting future revenue streams. Analyst consensus is strongly bullish with a $9.67 price target, indicating 25.7% upside.
The outlook hinges on execution of new partnerships and pipeline progress, particularly ABCL635 Phase 2 data expected in Q3 2026. Key risks include persistent cash burn, high valuation multiples despite losses, and biotech sector volatility. Investors should weigh the strong analyst support against fundamental challenges and the stock's current technical overbought condition.
GXO trades at $51.16, down 1.52% today, with a bullish technical signal from moving averages and strong analyst support. Recent earnings beats and a record sales pipeline of $2.7 billion highlight operational momentum. The company secured multiple long-term partnerships in Europe, reinforcing its contract logistics leadership.
Outlook remains positive with a consensus price target of $69.33, implying 35% upside. Risks include Amazon's market entry and retail sector exposure. Revenue growth and margin expansion in 2026 forecasts support a bullish case, though competition and macro pressures warrant monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About GXO Logistics Inc
GXO is the world's largest pure-play contract logistics provider. It offers cutting-edge supply chain solutions, including automated warehousing and fulfillment, for global blue-chip companies.
Read more on GXO →
